Prudential Financial
OVID icon

Prudential Financial’s Ovid Therapeutics OVID Stock Holding History

Prudential Financial’s Portfolio OVID Stock Details OVID Fund Activity
Bought
Maintained
Sold
Quarter Market Value Status Shares Change in
Stake 		Trade Value Portfolio Weight Portfolio Position
2026
Q2 		$62.1K Buy
+23,095
New +$59.6K ﹤0.01% 2392
2021
Q2 		– Sell
-11,262
Closed -$45K – 2606
2021
Q1 		$45K Buy
+11,262
New +$37.4K ﹤0.01% 2460

Other funds holding OVID

JT
Jupiter Topco New York $245B AUM
EAM
Eventide Asset Management Boston, Massachusetts $7.48B AUM 104.76% 1-Year Est. Return
BlackRock
BlackRock New York $6.73T AUM 46.02% 1-Year Est. Return
RCM
RA Capital Management Boston, Massachusetts $11.5B AUM 168.77% 1-Year Est. Return
AAA
Affinity Asset Advisors New York $2.21B AUM 431.26% 1-Year Est. Return
State Street
State Street Boston, Massachusetts $3.38T AUM 44.17% 1-Year Est. Return
Vanguard Capital Management
Vanguard Capital Management Malvern, Pennsylvania $4.68T AUM
ACM
ADAR1 Capital Management Austin, Texas $2.19B AUM 374.99% 1-Year Est. Return
Balyasny Asset Management
Balyasny Asset Management Chicago, Illinois $80.2B AUM 51.53% 1-Year Est. Return
Adage Capital Partners
Adage Capital Partners Boston, Massachusetts $71.3B AUM 56.8% 1-Year Est. Return

Prudential Financial's OVID Position: Q2 2026 in Review

Prudential Financial opened a new position in Ovid Therapeutics (OVID) in Q2 2026: 23,095 shares worth $62.1K. The stake represents ﹤0.01% of the portfolio and ranks #2392 among its holdings. This is a return to the name: Prudential Financial previously reported a position in OVID as recently as Q1 2021.

Prudential Financial first reported a position in OVID in Q1 2021 and has held it in 2 quarters since. 130 funds tracked by Wall St. Rank hold OVID as of Q2 2026.

  • Prudential Financial held 23,095 shares of Ovid Therapeutics worth $62.1K as of Q2 2026.
  • Ovid Therapeutics was a new Prudential Financial position in Q2 2026.
  • Ovid Therapeutics made up ﹤0.01% of Prudential Financial's portfolio in Q2 2026, its #2392 holding.
  • Prudential Financial first reported a position in Ovid Therapeutics in Q1 2021 and has held it in 2 quarters since.
  • 130 funds tracked by Wall St. Rank held Ovid Therapeutics as of Q2 2026.

Based on Prudential Financial's 13F filing for Q2 2026, filed 12 Aug 2026.